Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 9 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LISATA THERAPEUTICS, INC. | 104,925 | reported | 09 Jan 2026 | tx 5+104,925 |
| DURECT CORP | 0 | reported | 11 Sept 2025 | tx 20+223,500−32,250 |
| Xenon Pharmaceuticals Inc. | 0 | reported | 19 Dec 2023 | tx 39+182,830−49,283 |
| SUPERGEN INC | 0 | reported | 11 Oct 2013 | tx 11+1,100,000−1,108,753 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jan 2026 | GRANT_AWARD | LISATA THERAPEUTICS, INC. | 30,456 | 0.00 USD | |
| 11 Sept 2025 | TENDER | DURECT CORP | 6,000 | — | |
| 11 Sept 2025 | OTHER | DURECT CORP | 7,000 | — | deriv |
| 11 Sept 2025 | OTHER | DURECT CORP | 2,750 | — | deriv |
| 11 Sept 2025 | OTHER | DURECT CORP | 5,500 | — | deriv |
| 11 Sept 2025 | OTHER | DURECT CORP | 5,500 | — | deriv |
| 11 Sept 2025 | OTHER | DURECT CORP | 5,500 | — | deriv |
| 09 Jan 2025 | GRANT_AWARD | LISATA THERAPEUTICS, INC. | 15,789 | 0.00 USD | |
| 25 Sept 2024 | GRANT_AWARD | DURECT CORP | 5,500 | 0.00 USD | deriv |
| 09 Jan 2024 | GRANT_AWARD | LISATA THERAPEUTICS, INC. | 19,480 | 0.00 USD | |
| 19 Dec 2023 | EXERCISE | Xenon Pharmaceuticals Inc. | 823 | 9.85 USD | |
| 19 Dec 2023 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,497 | 9.85 USD | |
| 19 Dec 2023 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,497 | 0.00 USD | deriv |
| 19 Dec 2023 | EXERCISE | Xenon Pharmaceuticals Inc. | 823 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | DURECT CORP | 5,500 | 0.00 USD | deriv |
| 02 Jun 2023 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 18,475 | 0.00 USD | deriv |
| 09 Jan 2023 | GRANT_AWARD | LISATA THERAPEUTICS, INC. | 20,000 | 0.00 USD | |
| 12 Dec 2022 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,086 | 2.68 USD | |
| 12 Dec 2022 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,086 | 0.00 USD | deriv |
| 15 Sept 2022 | GRANT_AWARD | LISATA THERAPEUTICS, INC. | 19,200 | 6.25 USD | |
| 28 Jun 2022 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 18,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | DURECT CORP | 55,000 | 0.00 USD | deriv |
| 24 May 2022 | PURCHASE | DURECT CORP | 5,000 | 0.39 USD | |
| 24 May 2022 | PURCHASE | DURECT CORP | 5,000 | 0.38 USD | |
| 24 May 2022 | PURCHASE | DURECT CORP | 5,000 | 0.39 USD |
1 purchase reported after at least 12 months of silence — most recent on 16 May 2022.